Lino Biotech raises €1.0M Seed round
17 November 2020· Zurich, Switzerland· health, biotech, nanotechnology, optics, biosensors, b2b, software_hardware
The funding will be used to further develop and commercialize Focal Molography, a novel label-free biosensor platform for modern drug screening, and to study molecular interactions in living cells and crude biosystems.
Investors
LeadHigh-Tech Gründerfonds
Also participating
Roche Venture FundBioTools InnovatorMedTech Innovatorseveral family offices
About Lino Biotech
Stage
Seed
Headquarters
Zurich, Switzerland
Founded
2020
Team Size
6–20
Sectors
healthbiotechnanotechnologyopticsbiosensorsb2bsoftware_hardware